Pharmacotherapy of chronic hepatitis C virus infection – the IDEAL trial: ‘2b or not 2b (= 2a), that is the question’

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.10, Iss.17, 2009-12, pp. : 2845-2857

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Peginterferon-α-2b: Autoimmune hepatitis in a patient with chronic hepatitis C virus and HIV infections: case report

Reactions Weekly, Vol. 1, Iss. 1230, 2008-01 ,pp. : 28-29

Adis International

Access to resources Recommend Favorite

Peginterferon alfa-2b and ribavirin combination therapy for chronic hepatitis C

By Yeh Frank Gordon Fredric D

Future Virology, Vol. 2, Iss. 6, 2007-11 ,pp. : 553-563

Future Medicine

Access to resources Recommend Favorite

Interferon (IFN)- -2b is effective in patients with mild chronic hepatitis C

Inpharma, Vol. 1, Iss. 1279, 2001-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Peginterferon-α_2a for the treatment of hepatitis B infection

By Cooksley W Graham E

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 8, 2005-07 ,pp. : 1373-1380

Informa Healthcare

Access to resources Recommend Favorite

Recurrent hepatitis C virus (HCV) infection after liver transplantation "can be safely treated" with PEG interferon (IFN)- -2b and ribavirin

Inpharma, Vol. 1, Iss. 1429, 2004-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite